Food and Drug Administration v. Alliance for Hippocratic Medicine, No. 23-235 [Arg: 3.26.2024]
Supreme Court of the United States
English - March 27, 2024 13:11 - 1 hour - 42.6 MB - ★★★★★ - 2 ratingsPolitics News justice supreme court usa united states docket Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Harrow v. Department of Defense, No. 23-21 [Arg: 3.25.2024]
Next Episode: Erlinger v. U.S., No. 23-370 [Arg: 3.27.2024]
QUESTION PRESENTED:
Whether respondents have Article III standing to challenge the Food and Drug Administration’s 2016 and 2021 actions with respect to mifepristone’s approved conditions of use;whether the FDA’s 2016 and 2021 actions were arbitrary and capricious; andwhether the district court properly granted preliminary relief.